I’ve undergone at least three – maybe four – breast MRIs (magnetic resonance imaging). And until I started working on this article, I had no idea that those imaging studies might pose a long-term risk to my health.
Karen Calechman didn’t know about the potential health risks of MRIs with a contrast agent – a dye – either when she reported for her breast MRI. Like me, Calechman has a higher-than-normal risk of developing breast cancer. Her healthcare provider, like mine, ordered the imaging study to check for cancerous tumors. But after she read a facility-provided form titled, “Important Patient Information About Gadolinium-Based Contrast Agent,” Calechman hesitated.